PUBLICATION, USE OF NAME. Neither Party shall issue any press release, publicity or other form of public written disclosure related to this Agreement, the activities conducted hereunder, or the other Party without the prior written consent of the other Party, which consent shall not be unreasonably withheld, conditioned, or delayed. Except as otherwise required by, or in the good faith determination by a Party, complies with, Law or securities disclosure rules or guidance, or as required by the terms of this Agreement or mutually agreed upon by the Parties, neither Party shall make any use of the name of the other Party in any advertising or promotional material, or otherwise, without the prior written consent of the other Party.
PUBLICATION, USE OF NAME. 9.1 Mount Sinai and Sponsor recognize the traditional freedom of all scientists to publish and present promptly the results of the Sponsored Research. Mount Sinai and Sponsor also recognize that Patent Rights can be jeopardized by public disclosure prior to the filing of appropriate patent applications. Therefore, Mount Sinai agrees that each proposed publication or other public disclosure of the results of the Sponsored Research (“Manuscript”), prior to submission to a publisher or other public disclosure, will be submitted to Sponsor for review. Sponsor will have thirty (30) days from the date submitted in which to review such Manuscript. If within said thirty (30) day period, Sponsor notifies the Principal Investigator in writing that the Manuscript includes Sponsor’s Confidential Information, specifically pointing out where such Confidential Information appears in the Manuscript then the Principal Investigator will remove such Confidential Information from the Manuscript prior to submission for publication or making any other public disclosure of the Manuscript. If within said same thirty (30) day period, Sponsor requests in writing a delay of publication to allow for patent application filing, then the Principal Investigator will delay submission for publication or other public disclosure until the sooner of (a) ninety (90) days from the date of the initial submission of the Manuscript to Sponsor, or (b) the filing of such patent application. When requested by the Principal Investigator in advance, Sponsor, at its discretion, may allow for simultaneous submission of the Manuscript to the publisher and Sponsor.
9.2 Mount Sinai will not use Sponsor’s name without Sponsor’s prior written consent except that, without such consent, Mount Sinai or Principal Investigator may acknowledge Sponsor in scientific publications as appropriate per scientific custom and in listings of sponsored research projects. Sponsor shall not use Mount Sinai’s logo, name or the name of any Mount Sinai trustee, officer, faculty member, student, or employee, or any adaptation thereof without Mount Sinai’s prior written consent. In cases where Mount Sinai has given such consent, Sponsor agrees to cooperate with Mount Sinai with respect to any conditions or limitations imposed upon such name usage. For Mount Sinai, such consent may only be granted with prior, written approval by Mount Sinai Innovation Partners. Notwithstanding the foregoing, Sponsor may use Mount Sinai’s name (but n...
PUBLICATION, USE OF NAME. 7.1 SPONSOR acknowledges that the basic objective of research activities at PENN is the generation of new knowledge and its expeditious dissemination. To further that objective, PENN retains the right, at its discretion, to demonstrate, publish or publicize a description of the results of the SPONSORED RESEARCH, subject to the provisions of Section 8.2 below.
7.2 Should the PRINCIPAL INVESTIGATOR desire to disclose publicly, in writing or by oral presentation, the results of the SPONSORED RESEARCH, the PRINCIPAL INVESTIGATOR shall notify SPONSOR and PENN in writing of his or her intention at least thirty (30) days before such disclosure. The PRINCIPAL INVESTIGATOR shall include with such notice a description of the oral presentation or, in the case of a manuscript or other proposed written disclosure, a current draft of such written disclosure. SPONSOR may request PENN, no later than thirty (30) days following the receipt of such notice, to file a patent, copyright or other application related to PENN INTELLECTUAL PROPERTY contained in such disclosure. All such filings shall be subject to the provisions of ARTICLE 5 of this Agreement. Upon receipt of such request, PENN and the PRINCIPAL INVESTIGATOR shall arrange a short delay in publication not to exceed sixty (60) days, to permit filing of a patent application, copyright or other application by PENN.
7.3 PENN agrees not to use the SPONSOR's name without the SPONSOR's prior written consent except that PENN may acknowledge the SPONSOR's funding of this SPONSORED RESEARCH in scientific publications and in listings of SPONSORED RESEARCH projects. SPONSOR agrees not to use PENN's name, or the name of any trustee, officer, faculty member, student or employee thereof, except in a manner consistent with the provisions of the LICENSE AGREEMENT.
PUBLICATION, USE OF NAME. 10.1 Mount Sinai and LifeMap recognize the traditional freedom of all scientists to publish and present promptly the results of the Development Activities. Mount Sinai and LifeMap also recognize that exclusive patent rights can be jeopardized by public disclosure prior to the filing of suitable patent applications. Therefore, Mount Sinai agrees that each proposed publication, before submission to a publisher, will be submitted to LifeMap; LifeMap will have [*Certain information has been omitted under a request for confidential treatment, and the omitted information has been filed with the Commission] days in which to review such proposed publication. If within said [*Certain information has been omitted under a request for confidential treatment, and the omitted information has been filed with the Commission] day period, LifeMap notifies the Principal Investigator in writing that the proposed publication includes LifeMap’s Confidential Information, specifically pointing out where such Confidential Information appears in the proposed publication, then the proposed publication shall not be submitted for publication or otherwise be publicly disclosed until Principal Investigator has removed such Confidential Information. If within said same [*Certain information has been omitted under a request for confidential treatment, and the omitted information has been filed with the Commission] day period, LifeMap requests in writing that Mount Sinai and Principal Investigator delay publication to allow for patent filing, then Mount Sinai and Principal Investigator will delay publication for up to [*Certain information has been omitted under a request for confidential treatment, and the omitted information has been filed with the Commission] days from the date of the initial submission of such proposed publication to LifeMap to permit patent application filing. When requested by Mount Sinai in advance, LifeMap, at its discretion, may allow for simultaneous submission of the proposed publication to the publisher and LifeMap. Scientists at both Mount Sinai and LifeMap will be expected to treat matters of authorship in a proper collaborative spirit, giving credit where it is due and proceeding in a manner that fosters cooperation and communication, but will not do anything in this regard that will jeopardize the issuance of a valid patent. With respect to Joint Results, the Parties agree to publish jointly, provided, however, that if the Parties have not submitted a joint...
PUBLICATION, USE OF NAME. 7.1 Apollon acknowledges that the basic objective of research activities at Penn is the generation of new knowledge and its expeditious dissemination. To further that objective, Penn retains the right, at its discretion, to demonstrate, publish or publicize the results of the Sponsored Research, subject to the provisions of Section 7.2 below.
7.2 Should Principal Investigator desire to disclose publicly, in writing or by oral presentation, the results of the Sponsored Research, Principal Investigator shall notify Xxxxxxx and Penn in writing of his intention at least thirty (30) days before such disclosure. The Principal Investigator shall include with such notice a description of the oral presentation or, in the case of a manuscript or other proposed written disclosure, a current draft of such written disclosure. Xxxxxxx may request Penn, no later than thirty (30) days following the receipt of such notice, to file a patent, copyright or other application related to such invention. All such filings shall be subject to the provisions of Article 4 of this Agreement. Upon receipt of such request, Penn shall arrange for and Principal Investigator agrees to a short delay in publication, not to exceed sixty (60) days, to permit filing of a patent application, copyright or other application by Penn or Apollon as provided by Section 4.2 hereof, or if Penn declines to file such application, to permit Xxxxxxx to make such a filing.
PUBLICATION, USE OF NAME. 9.1 Drexel shall be free to publish the results of the Sponsored Research, after providing the Sponsor with a thirty (30) day period in which to review each publication to identify patentable subject matter and to identify any inadvertent disclosure of the Sponsor’s proprietary information. If necessary to permit the preparation and filing U.S. patent applications, the Principal Investigator may agree to an additional review period not to exceed sixty (60) days. Any further extension will require subsequent agreement between the Sponsor and Drexel.
9.2 Neither Party will make any press or media announcements concerning this Agreement, or use the name, logo, insignia or trademarks of the other Party, or any version, abbreviation or representation of them or the names of any of Drexel’s trustees, officers, faculty, students, employees, or agents, in any advertising or other form of publicity, fund-raising, promotional materials or web sites, without the written permission of the other Party, except that Drexel may acknowledge Sponsor's funding of the Sponsored Research in scientific publications and in listings of sponsored research projects. Further, Sponsor shall not use the name of “Drexel University,” or any variation, adaptation or abbreviation thereof, or that of any of its trustees, officers, or agents, or any trademark owned by Drexel without Drexel’s written permission. Drexel’s Office of University Communications has sole authority to grant in writing to the Sponsor any approved use of the Drexel name, logo, insignia or trademark or the names of any of Drexel’s trustees, officers, faculty, students, employees, or agents in any press or media announcement.
PUBLICATION, USE OF NAME. Project data or results may not be published or referred to, in whole or in part, by Quintiles or its affiliates without the prior expressed written consent of Sponsor. Neither party will use the other party’s name in connection with any publication or promotion without the other party’s prior, written consent.
PUBLICATION, USE OF NAME. 9.1 Mount Sinai and Miromatrix recognize the traditional freedom of all scientists to publish and present promptly the results of their research. Mount Sinai and Miromatrix also recognize that exclusive patent rights can be jeopardized by public disclosure prior to the filing of suitable patent applications. Mount Sinai agrees not to disclose Miromatrix Results. Mount Sinai also agrees that first public disclosure of the Mount Sinai Results will be in accordance with the following. Mount Sinai agrees that Principal Investigator shall submit each proposed first publication of Project results and Project data (“Manuscript”), before submission to a publisher or other public disclosure, to Miromatrix for review. Miromatrix shall have forty-five (45) days after such submission to notify Principal Investigator in writing of any Miromatrix Confidential Information appearing in such Manuscript and request its removal, in which event Principal Investigator shall remove such Confidential Information prior to submission for publication or other public disclosure of such Manuscript. Within said same forty-five (45) day period, Miromatrix may request in writing that Principal Investigator delay submission for publication or other public disclosure of such Manuscript for patent filing purposes, for a period not to exceed ninety (90) days from the initial disclosure of such Manuscript to Miromatrix.
9.2 Miromatrix agrees not to use Mount Sinai’s name, or the name of any trustee, officer, faculty member, student or employee thereof (or any adaptation of any of the foregoing), without Mount Sinai’s prior written consent, except that Miromatrix may (a) list Mount Sinai as a collaborator relating to the Project and (b) to the extent required by law, may list Mount Sinai as a collaborator in any other place. For clarity, name use permitted without prior approval does not include use of Mount Sinai’s name as an endorsement of any Miromatrix product or service.
PUBLICATION, USE OF NAME. 8.1 DUCOM shall be free to publish the results of the SPONSORED RESEARCH; a copy of each publication will be provided to SPONSOR.
8.2 DUCOM shall not use SPONSOR's name without SPONSOR's prior written consent except that DUCOM may acknowledge SPONSOR's funding of the SPONSORED RESEARCH in scientific publications and in listings of sponsored research projects. SPONSOR shall not use DUCOM's name, or the name of any trustee, officer, faculty member, student or employee thereof, without DUCOM's prior written consent.
PUBLICATION, USE OF NAME
